Newswise Feature Channel: Parkinson’s Disease

Combining Long- and Short-Read Sequencing in Single Cells Reveals New mRNAs in Neurodegenerative Diseases

Sanford Burnham Prebys — Thu, 19 Dec 2024 20:25:10 EST

Researchers led by Jerold Chun MD, PhD, professor in the Degenerative Diseases Program at Sanford Burnham Prebys, published results December 10, 2024, in eNeuro from combining two sequencing technologies in single cells to find new differences in mRNAs resulting from Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease.

A Pioneer in Brain Imaging Wins NJIT's 2024 Excellence in Research Award

New Jersey Institute of Technology (NJIT) — Thu, 19 Dec 2024 19:20:12 EST

Bharat Biswal, a pioneer in the field of neural imaging who developed a technique that sheds new light on brain-related diseases and injuries, is this year's winner of NJIT's Excellence in Research award.

Worsening Heat Waves Pose Unique Risks to People Living with Neurodegenerative Disease

University of California, Los Angeles (UCLA), Health Sciences — Tue, 17 Dec 2024 21:25:18 EST

As 2024 is set to end as Earth's hottest year on record - breaking the previous record set in 2023- a UCLA Health researcher says people living with neurodegenerative diseases will be uniquely vulnerable to worsening heat waves because of a higher risk of heat-related complications.

FAU's Randy D. Blakely, Ph.D., Honored as a Prestigious ASPET Fellow

Florida Atlantic University — Tue, 17 Dec 2024 08:30:53 EST

Randy D. Blakely, Ph.D., has been named a Fellow of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Designation as an ASPET Fellow recognizes leaders in the field for their exceptional contributions to pharmacological research, education, mentorship and leadership.

UdeM Receives $8M to Study the Link Between the Immune System and Parkinson's Disease

Universite de Montreal — Fri, 13 Dec 2024 17:00:34 EST

A team led by Michel Desjardins, a professor in the Faculty of Medicine, has secured $8M from ASAP to study the connection between the immune system and Parkinson's disease.

Unlocking the Secrets of the Mind

Virginia Tech — Wed, 11 Dec 2024 08:00:59 EST

"When you're deciding whether to turn left or right, or to eat the chocolate cake or the carrots, what's happening in your brain?" This simple question masks a complex web of brain activity. Computational neuroscientists are determined to untangle the web.

Study May Reverse Century-Old Understanding of the Shape of 'Arms' on Mammals' Brain Cells

Johns Hopkins Medicine — Mon, 02 Dec 2024 05:00:00 EST

Biology textbooks may need a revision, say Johns Hopkins Medicine scientists, who present new evidence that an armlike structure of mammalian brain cells may be a different shape than scientists have assumed for more than a century.

Elevated Parkinsonism Symptoms in Autism During Middle and Older Adulthood Are Linked with Psychosocial, Physical Health, and Mental Health Outcomes

George Washington University — Fri, 22 Nov 2024 09:15:55 EST

Ochsner Health Selected as a Site for Global Parkinson's Disease Study Researching the Black and African American Population

Ochsner Health — Thu, 21 Nov 2024 10:00:16 EST

Ochsner Health, a leading nonprofit healthcare provider in the Gulf South, has been selected by the Global Parkinson's Genetics Program (GP2) as one of six new study sites for the Black and African American Connections to Parkinson's Disease study.

Parkinson's Drug Changes the Gut Microbiome for the Worse Due to Iron Deficiency

University of Vienna — Thu, 21 Nov 2024 06:00:56 EST

In a groundbreaking new study, conducted within the framework of the FWF-funded Cluster of Excellence "Microbiomes drive Planetary Health", scientists from the University of Vienna, in collaboration with the University of Southampton, Aalborg University and Boston University, have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The study, published in Nature Microbiology, provides new insights into the often-overlooked impact of human-targeted drugs on the microbial communities that play a critical role in human health.

AI Speaks Volumes When It Comes to Detecting Parkinson's Disease

University of South Australia — Wed, 20 Nov 2024 20:20:02 EST

Algorithms that can detect subtle changes in a person's voice are emerging as a potential new diagnostic tool for Parkinson's disease, according to researchers from Iraq and Australia.

Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, Olea europaea L., in Long COVID and Other Conditions Involving Cognitive Impairment

National Center For Scientific Research Demokritos — Fri, 08 Nov 2024 13:15:31 EST

Out-of-Pocket Costs Continue to Rise for Neurologic Medications

Ohio State University Wexner Medical Center — Thu, 31 Oct 2024 12:45:39 EST

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological diseases - epilepsy, multiple sclerosis (MS), peripheral neuropathy, Alzheimer's disease and Parkinson's disease. This is according to research published online in Neurology(r), the medical journal of the American Academy of Neurology.

Costs Still on the Rise for Drugs for Neurological Diseases

American Academy of Neurology (AAN) — Wed, 30 Oct 2024 16:00:00 EST

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS drugs, according to a study published in the October 30, 2024, online issue of Neurology(r), the medical journal of the American Academy of Neurology.

Antibiotics and Antifungals May Slightly Affect Parkinson's Risk, Study Finds

Rutgers University-New Brunswick — Wed, 23 Oct 2024 12:15:52 EST

New research by Rutgers Health researchers highlights a complex relationship between bacteria in the digestive tract and brain health.

Speech Accessibility Project expands to Canada

Fri, 18 Oct 2024 10:55:22 EST

The Speech Accessibility Project is now recruiting Canadian adults with Parkinson's disease, cerebral palsy, amyotrophic lateral sclerosis, Down syndrome and those who have had a stroke.

Protein Shakeup: Researchers Uncover New Function of a Protein That May Unlock Age-Related Illnesses

McMaster University — Thu, 17 Oct 2024 20:35:42 EST

McMaster University researchers have discovered a previously unknown cell-protecting function of a protein, which could open new avenues for treating age-related diseases and lead to healthier aging overall.

High Flux Isotope Reactor a Fit for Nobel Laureate's Designer Proteins

Oak Ridge National Laboratory — Wed, 16 Oct 2024 15:45:27 EST

Biochemist David Baker -- just announced as a recipient of the Nobel Prize for Chemistry -- turned to the High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory for information he couldn't get anywhere else. HFIR is the strongest reactor-based neutron source in the United States.

HLTH 2024: Cedars-Sinai Accelerator Hosts Demo Day

Cedars-Sinai — Wed, 16 Oct 2024 12:30:09 EST

Participants from the Cedars-Sinai Accelerator's 10th class are set to showcase their leading-edge healthcare solutions during Demo Day at HLTH 2024 on Tuesday, Oct. 22, from 2:30 p.m. to 4 p.m. at The Venetian Expo Center in Las Vegas, Nevada.

Challenging Current Understanding, Study Reveals Rapid Release of Dopamine Not Needed for Initiating Movement

Harvard Medical School — Wed, 16 Oct 2024 11:00:00 EST

At a glance: Study in mice reveals rapid release of dopamine is not needed for initiating movement but is important for activities related to reward-seeking and motivation. The findings help explain why the widely used Parkinson's drug levodopa improves movement-related symptoms but often fails to ameliorate some cognitive ones. The work may inform the development of new therapies that restore both slow and fast dopamine action to treat multiple symptoms.